Thymosin Alpha-1 is a 28 amino acid peptide that your thymus gland makes naturally. The thymus is where your T cells learn to tell friend from foe, and it shrinks steadily as you age, which is one reason immune function tends to fade over time. Thymosin Alpha-1 is the synthetic version of one of the signals that gland puts out.
It is the immune counterpart to a peptide you may already know. TB-500 is thymosin beta-4, the tissue repair side of the thymus story. Thymosin Alpha-1 is the immune side.
What sets it apart from most peptides discussed in this space is that it is a real approved medicine in much of the world. Sold as Zadaxin, it is licensed in more than 30 countries for chronic hepatitis B and hepatitis C, and as an add-on to help the immune system during cancer treatment and vaccination. That means it has been through proper trials and has a documented safety record, which is unusual for anything in the research peptide world.
KPV is about as small as a peptide gets. It is three amino acids, lysine, proline, and valine, snipped from th…
LL-37 is part of a family of peptides your immune system produces called cathelicidins. It's made by immune ce…
Semax occupies an unusual position in the peptide world: it's one of the very few research peptides that is ac…
It is not approved in the United States. American access runs through compounding pharmacies, and US regulators have placed it in the restricted category that limits how freely those pharmacies can prepare it.
For educational and research purposes only. Never use any peptide or substance based on information found here — always consult a licensed healthcare professional before making any medical or health-related decision.
Thymosin Alpha-1 works through a receptor called TLR9 on dendritic cells, which are the cells that show threats to the rest of the immune system. Activating that pathway pushes the immune response toward the Th1 pattern, the arm that deals with viruses and infected cells, and raises natural killer cell activity.
The hepatitis B evidence is the strongest. Phase III work reported a sustained response in roughly 36 percent of treated patients compared with about 20 percent on placebo at 72 weeks. That is a real effect from a properly controlled trial, and it is the basis for the approvals it holds outside the United States.
There is also a growing body of work in critical illness. A systematic review and meta-analysis in severe acute pancreatitis found it reduced infections and helped regulate the immune response. It was studied during SARS and later COVID-19 for the same reason, on the theory that severe viral illness involves immune exhaustion that this peptide may partly correct.
The honest limitation is that almost all of this evidence sits in specific disease settings, mostly hepatitis and serious infection. There is very little research on healthy adults taking it for general immune support or longevity, which is how it is most often marketed online.
No reviews yet. Be the first.